PRELUDE CAPITAL MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 101 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$426,000
+161.3%
157,247
+84.1%
0.02%
+150.0%
Q2 2018$163,000
+3975.0%
85,412
+3458.8%
0.01%
Q2 2017$4,000
-97.7%
2,400
-95.5%
0.00%
-100.0%
Q1 2017$173,000
+133.8%
53,700
-1.5%
0.02%
+88.9%
Q4 2016$74,000
+252.4%
54,500
+300.7%
0.01%
+350.0%
Q3 2016$21,000
-12.5%
13,600
-25.7%
0.00%
-33.3%
Q2 2016$24,000
+100.0%
18,300
+698.1%
0.00%
+50.0%
Q1 2016$12,000
-70.0%
2,293
-55.2%
0.00%
-66.7%
Q4 2015$40,000
-46.7%
5,123
-25.8%
0.01%
-40.0%
Q2 2015$75,000
+66.7%
6,900
+115.6%
0.01%
+66.7%
Q1 2015$45,000
-75.8%
3,200
-70.9%
0.01%
-77.8%
Q4 2014$186,000
+675.0%
11,000
+450.0%
0.03%
+800.0%
Q1 2014$24,000
+242.9%
2,000
+300.0%
0.00%
+200.0%
Q4 2013$7,000
-58.8%
500
-50.0%
0.00%
-66.7%
Q3 2013$17,000
-89.6%
1,000
-90.0%
0.00%
-91.4%
Q2 2013$163,000
-95.2%
10,048
-85.8%
0.04%
-94.5%
Q1 2013$3,419,00070,5480.64%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,100,000$14,762,0006.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,882,805$52,107,0001.90%
Cheyne Capital Management (UK) LLP 326,821$4,388,0001.56%
BB BIOTECH AG 2,320,737$31,144,0001.27%
Broadfin Capital, LLC 854,384$11,466,0001.20%
HealthCor Management, L.P. 1,162,200$15,597,0000.80%
Orbimed Advisors 4,736,900$63,569,0000.66%
Rhenman & Partners Asset Management AB 148,000$1,986,0000.58%
SOUND ENERGY PARTNERS, INC. 51,000$684,0000.53%
Rock Springs Capital Management LP 210,000$2,818,0000.44%
View complete list of INFINITY PHARMACEUTICALS INC shareholders